Artia Global Partners LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Artia Global Partners LP disclosed 50 US equity positions worth $622.4m in its Q4 2025 13F filing. The largest position was INSM at 19.1% of the reported book, followed by ABVX and ARGX. Against the Q3 2025 filing, it opened 19 new positions, added to 13 and reduced 7 among the top 50 holdings.
What did Artia Global Partners LP own in Q4 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 19.1% | $118.7m | 682,212 | -7% | reduced |
| 2 | ABVX ABIVAX SA | 13.0% | $81.0m | 600,747 | 166% | added | |
| 3 | ARGX ARGENX SE | Healthcare | 8.7% | $54.4m | 64,699 | -17% | reduced |
| 4 | LLY ELI LILLY & CO | Healthcare | 8.7% | $54.3m | 50,500 | 76% | added |
| 5 | VKTX VIKING THERAPEUTICS INC | Healthcare | 4.1% | $25.3m | 719,365 | 392% | added |
| 6 | TRVI TREVI THERAPEUTICS INC | Healthcare | 4.1% | $25.2m | 2,013,602 | 1% | added |
| 7 | SLNOEUR SOLENO THERAPEUTICS INC | 4.0% | $24.7m | 533,698 | -21% | reduced | |
| 8 | PROSHARES TR II | 3.9% | $24.5m | 442,119 | -18% | reduced | |
| 9 | QURE UNIQURE NV | 3.9% | $24.5m | 1,023,539 | 55% | added | |
| 10 | NEWAMSTERDAM PHARMA COMPANY | 2.8% | $17.7m | 503,936 | 159% | added | |
| 11 | AZN ASTRAZENECA PLC | Healthcare | 2.8% | $17.5m | 190,752 | 0% | held |
| 12 | CDTX CIDARA THERAPEUTICS INC | 2.5% | $15.6m | 70,824 | – | new | |
| 13 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 2.3% | $14.0m | 767,098 | 22% | added |
| 14 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.8% | $11.4m | 144,376 | 140% | added |
| 15 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.4% | $8.5m | 205,090 | 89% | added |
| 16 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.3% | $8.3m | 104,190 | 0% | held |
| 17 | DGX QUEST DIAGNOSTICS INC | Healthcare | 1.1% | $7.1m | 40,817 | -50% | reduced |
| 18 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.1% | $6.9m | 17,400 | -50% | reduced |
| 19 | VTYXUSD VENTYX BIOSCIENCES INC | 1.0% | $6.3m | 695,982 | – | new | |
| 20 | PVLA PALVELLA THERAPEUTICS INC NE | 1.0% | $6.2m | 59,200 | – | new | |
| 21 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.8% | $5.0m | 137,800 | 143% | added |
| 22 | SION SIONNA THERAPEUTICS INC | 0.8% | $4.9m | 119,741 | – | new | |
| 23 | PALI PALISADE BIO INC | Healthcare | 0.8% | $4.7m | 1,992,367 | – | new |
| 24 | RNAGBP AVIDITY BIOSCIENCES INC | 0.7% | $4.3m | 60,100 | -45% | reduced | |
| 25 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.7% | $4.2m | 96,285 | 0% | held |
| 26 | RAPP RAPPORT THERAPEUTICS INC | 0.7% | $4.2m | 138,508 | 114% | added | |
| 27 | PROK PROKIDNEY CORP | 0.7% | $4.1m | 1,838,411 | – | new | |
| 28 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.6% | $3.8m | 17,740 | 45% | added |
| 29 | ABBV ABBVIE INC | Healthcare | 0.5% | $3.3m | 14,500 | 0% | held |
| 30 | BLTE BELITE BIO INC | Healthcare | 0.5% | $2.9m | 17,989 | – | new |
| 31 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.5% | $2.8m | 129,800 | – | new |
| 32 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.4% | $2.7m | 70,700 | 129% | added |
| 33 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.4% | $2.6m | 33,407 | – | new |
| 34 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.4% | $2.4m | 5,000 | 0% | held |
| 35 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.3% | $2.0m | 22,951 | 0% | held |
| 36 | UPB UPSTREAM BIO INC | 0.3% | $1.9m | 68,653 | – | new | |
| 37 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.3% | $1.8m | 40,000 | 0% | held |
| 38 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.3% | $1.7m | 141,061 | 0% | held |
| 39 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.3% | $1.6m | 20,400 | 0% | held |
| 40 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 0.3% | $1.6m | 41,600 | 0% | held |
| 41 | PEPG PEPGEN INC | Healthcare | 0.2% | $1.3m | 205,324 | – | new |
| 42 | CELC CELCUITY INC | Healthcare | 0.2% | $1.3m | 12,900 | – | new |
| 43 | KINIKSA PHARMACEUTICALS INTL | 0.2% | $1.2m | 29,200 | 0% | held | |
| 44 | NUVALENT INC | 0.1% | $814.8k | 8,100 | – | new | |
| 45 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.1% | $754.9k | 41,570 | – | new |
| 46 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.1% | $736.9k | 2,500 | – | new |
| 47 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.1% | $519.6k | 29,192 | – | new |
| 48 | TENX TENAX THERAPEUTICS INC | 0.1% | $513.0k | 42,080 | – | new | |
| 49 | KOD KODIAK SCIENCES INC | Healthcare | 0.1% | $475.9k | 17,019 | – | new |
| 50 | LYRA THERAPEUTICS INC | 0.0% | $27.0k | 8,756 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.